STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 95 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $353,000 | -59.1% | 73,061 | -10.2% | 0.00% | -100.0% |
| Q4 2019 | $864,000 | +159.5% | 81,351 | +154.6% | 0.00% | – |
| Q3 2019 | $333,000 | +17.3% | 31,948 | +72.1% | 0.00% | – |
| Q2 2019 | $284,000 | +6.8% | 18,561 | -9.8% | 0.00% | – |
| Q1 2019 | $266,000 | +100.0% | 20,580 | +46.6% | 0.00% | – |
| Q4 2018 | $133,000 | -81.8% | 14,041 | -69.2% | 0.00% | -100.0% |
| Q2 2018 | $732,000 | +293.5% | 45,598 | +172.1% | 0.00% | – |
| Q3 2017 | $186,000 | +51.2% | 16,756 | +45.9% | 0.00% | – |
| Q4 2016 | $123,000 | +70.8% | 11,483 | +8.7% | 0.00% | – |
| Q2 2016 | $72,000 | -41.9% | 10,567 | +0.2% | 0.00% | – |
| Q2 2015 | $124,000 | -69.5% | 10,545 | -55.7% | 0.00% | – |
| Q4 2014 | $406,000 | +161.9% | 23,809 | +125.5% | 0.00% | – |
| Q2 2014 | $155,000 | -77.5% | 10,557 | -68.8% | 0.00% | -100.0% |
| Q1 2014 | $689,000 | -19.1% | 33,812 | -22.2% | 0.00% | 0.0% |
| Q4 2013 | $852,000 | – | 43,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
| NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
| Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
| Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
| KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
| Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
| Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
| Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
| Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |